Canada Markets open in 6 hrs 20 mins

Canntab Therapeutics Limited (CTABF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.56090.0000 (0.00%)
At close: 11:46AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.5609
Open0.5599
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5609 - 0.5609
52 Week Range0.4798 - 0.8940
Volume200
Avg. Volume1,258
Market Cap20.034M
Beta (5Y Monthly)1.24
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar. 08, 2016
1y Target EstN/A
All
News
  • CNW Group

    Canntab Announces Agreement with Pathway Health

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has entered into a service agreement (the "Agreement") with Pathway Health Corporation ("PHC"). Pathway Health is one of the largest providers of out-of-hospital pain management services in Canada. The company owns and operates nine (9) community-based clinics a

  • CNW Group

    IIROC Trade Resumption - PILL

    Trading resumes in:

  • CNW Group

    Canntab Receives Medical Sales Licence from Health Canada

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that it has received its medical sales license from Health Canada for its Markham, Ontario facility, enabling the sale of all products directly to medical consumers.